Qiagen GmbH

QIAGEN is a global leader in molecular testing solutions, supporting more than 500,000 customers across research, diagnostics, and healthcare. With operational presence in 25 countries and a team comprising 75 nationalities, QIAGEN is trusted by leading academic researchers, pharmaceutical firms, clinical laboratories, and Nobel laureates for its reliable products and scientific expertise.

The extensive QIAGEN portfolio covers validated diagnostic panels, automation tools, and digital platforms, enhancing workflows for clinical, research, and industrial applications. QIAGEN’s GMP-compliant offerings help accelerate drug and companion diagnostic development by collaborating with CROs, CDMOs, and life science companies. Customisable products and services support small companies and start-ups via grants and tailored programmes, ensuring flexibility and scalability.

The company’s solutions enable users to extract actionable insights from DNA and RNA with end-to-end support from sample collection to analysis. Dedicated project management and product lifecycle support ensure high standards and efficiency throughout every stage. QIAGEN’s commitment to eco-friendly options and automation further supports laboratory productivity and sustainability.